Financials

  • Market Capitalization 84.75 M
  • Employee 76
  • Founded 2018
  • CEO N/A
  • Website www.acrivon.com
  • Headquarter Massachusetts, United States
  • FIGI BBG011RWR2Q4
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.19
Relación precio/flujo de caja
464.04

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4054
TELO
Telomir Pharmaceuticals, Inc. - Common Stock
1.24 USD+0.81%-0.80%-3.88%+5.08%85.28 M USD
4055
NRXS
Neuraxis, Inc. Common Stock
6.88 USD-3.64%-7.28%-1.15%+26.70%85.20 M USD
4062
RLYB
Rallybio Corporation - Common Stock
15.89 USD+1.02%+0.19%-0.50%+3431.11%84.19 M USD
4086
ENTX
Entera Bio Ltd. - Ordinary Shares
1.64 USD-1.20%-4.65%+31.20%-7.34%80.73 M USD

Noticias